Zirconium (89Zr) Crefmirlimab Berdoxam

5 trials 4 recruiting

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

4 Recruiting

1 Completed trials

4 Sponsors

3 Countries

Phase II/III

Phase II

Phase I/II

Phase II/III: 1 Phase II: 2 Phase I/II: 2

Indications tested

Malignant melanoma 1

Sponsors using this IMP

Universitair Medisch Centrum Groningen 2 Amsterdam UMC 1 Leids Universitair Medisch Centrum (LUMC) 1 Universitaetsklinikum Tuebingen AöR 1

All trials

5 total

CD8 PET imaging in metastatic solid tumours; A phase II, open label, multi-center study of 89Zr-DF-crefmirlimab for CD8 positron emission to… Recruiting

2024-515885-15-00 Phase I/II 2 countries Universitair Medisch Centrum Groningen
ACTME Recruiting

2024-516125-31-02 Phase I/II 1 country Leids Universitair Medisch Centrum (LUMC)
Imaging of inflamed arteries in giant cell arteritis and inflamed joints in rheumatoid arthritis with a PET/CT scan. Recruiting

2024-514489-38-01 Phase II 1 country Universitair Medisch Centrum Groningen
Early detection of side effects in patients with metastatic melanoma receiving immune checkpoint inhibitor therapy by investigation of the C… Recruiting

2024-512219-37-00 Phase II 1 country Universitaetsklinikum Tuebingen AöR
Evaluating T Cell Changes and Activation in Cancer Patient Using Two PET Tracers (iRelate) Ended

2023-509486-20-00 Phase II/III 1 country Amsterdam UMC

Showing 1–5 of 5 trials

← All drugs A–Z